AORN Journal
Volume 92, Issue 3 , Pages 288-296 , September 2010

Reducing Surgical Site Infections by Bundling Multiple Risk Reduction Strategies and Active Surveillance

References 

  1. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20(4):250–280
  2. Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1178–1187
  3. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36(5):592–598
  4. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol. 2004;25(6):461–467
  5. Cantlon CA, Stemper ME, Schwan WR, Hoffman MA, Qutaishat SS. Significant pathogens isolated from surgical site infections at a community hospital in the Midwest. Am J Infect Control. 2006;34(8):526–529
  6. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis. 2007;13(2):236–242
  7. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control. 2005;33(7):385–391
  8. Patel M, Kumar RA, Stamm AM, Hoesley CJ, Moser SA, Waites KB. USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol. 2007;45(10):3431–3433
  9. Beigi R, Hanrahan J. Staphylococcus aureus and MRSA colonization rates among gravidas admitted to labor and delivery: a pilot study. Infect Dis Obstet Gynecol. 2007;2007:70876
  10. Cheadle WG. Risk factors for surgical site infection. Surg Infect (Larchmt). 2006;7(Suppl 1):S7–S11
  11. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39(6):776–782
  12. Livingston B. Challenges and experience with implementing patient preoperative skin preparation in a Veterans Administration (VA) Health System to prevent surgical site infections. Poster presented at: Association for Professionals in Infection Control and Epidemiology (APIC), San Jose, CA; June 24, 2007 http://www.sageproducts.com/documents/pdf/education/symposia/ssi/20973_Challenges_and_Experience_with_Implementing_Patient_Preoperative_Skin_Preparation_in_a_Veterans_Administration_VA_Health_System_to_Prevent_Surgical_Site_Infections.pdfAccessed May 13, 2010
  13. Choban PS, Heckler R, Burge JC, Flancbaum L. Increased incidence of nosocomial infections in obese surgical patients. Am Surg. 1995;61(11):1001–1005
  14. Kabon B, Nagele A, Reddy D, et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology. 2004;100(2):274–280
  15. 5 Million Lives Campaign. Getting Started Kit: Prevent Surgical Site Infections How-to Guide. Cambridge, MA: Institute for Healthcare Improvement; 2008;
  16. Jackson MM. Topical antiseptics in healthcare. Clin Lab Sci. 2005;18(3):160–169
  17. DeBaun B. Evaluation of the antimicrobial properties of an alcohol-free 2% chlorhexidine gluconate solution. AORN J. 2008;87(5):925–933
  18. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA Chicago Antimicrobial Resistance Project (CARP). Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med. 2006;166(3):306–312
  19. Maki DG, Paulson DS. Prospective evaluation of 6 preoperative cutaneous antiseptic regimens for prevention of surgical site infection. March 2006;Poster presented at: Society for Healthcare Epidemiology of America (SHEA) Conference; Chicago, IL
  20. Edmiston CE, Seabrook GR, Johnson CP, Paulson DS, Beausoleil CM. Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control. 2007;35(2):89–96
  21. Leigh DA, Stronge JL, Marriner J, Sedgwick J. Total body bathing with “Hibiscrub” (chlorhexidine) in surgical patients: a controlled trial. J Hosp Infect. 1983;4(3):229–235
  22. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev. 2007;(2):CD004985
  23. Rhee H, Harris B. Reducing Surgical site infection: 2% CHG cloth reduces SSI rates by > 70% difference resulting in a $154,869 cost avoidance. May 23, 2007;Poster presented at: The Virginians Improving Patient Care and Safety (VIPC&S) 7th Annual Conference; Richmond, VA
  24. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med. 2007;167(19):2073–2079
  25. Blanchard K, Jefferson J, Mermel L. Control of nosocomial Acinetobacter in a university-affiliated medical center. June 2007;Poster presented at: Association for Professionals in Infection Control and Epidemiology (APIC) meeting; San Jose, CA
  26. Wernitz MH, Swidsinski S, Weist K, et al. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clin Microbiol Infect. 2005;11(6):457–465
  27. Nicholson MR, Huesman LA. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control. 2006;34(1):44–48
  28. Carrier M, Marchand R, Auger P, et al. Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit. J Thorac Cardiovasc Surg. 2002;123(1):40–44
  29. Washington State Department of Health, Tacoma-Pierce County Health Department, Group Health Cooperative, MultiCare Health Systems. Living with MRSA: Learning How to Control the Spread of Methicillin-Resistant Staphylococcus Aureus (MRSA). March 20, 2006;http://here.doh.wa.gov/materials/living-with-mrsa/12_MRSApage_E07L.pdfAccessed June 29, 2010

PII: S0001-2092(10)00659-9

doi: 10.1016/j.aorn.2010.01.016

AORN Journal
Volume 92, Issue 3 , Pages 288-296 , September 2010

Article Tools

* Image Usage & Resolution